Cargando…
Genistein treatment increases bone mass in obese, hyperglycemic mice
BACKGROUND: Obesity and type 2 diabetes mellitus are associated with elevated risk of limb bone fracture. Incidences of these conditions are on the rise worldwide. Genistein, a phytoestrogen, has been shown by several studies to demonstrate bone-protective properties and may improve bone health in o...
Autores principales: | Michelin, Richard M, Al-Nakkash, Layla, Broderick, Tom L, Plochocki, Jeffrey H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801201/ https://www.ncbi.nlm.nih.gov/pubmed/27042131 http://dx.doi.org/10.2147/DMSO.S97600 |
Ejemplares similares
-
Genistein treatment improves fracture resistance in obese diabetic mice
por: Odle, Britton, et al.
Publicado: (2017) -
Bone Strength Is Improved with Genistein Treatment in Mice with Diet-Induced Obesity
por: Hellings, Austin, et al.
Publicado: (2019) -
Genistein Suppresses IL-6 and MMP-13 to Attenuate Osteoarthritis in Obese Diabetic Mice
por: Lopez, Janelle, et al.
Publicado: (2023) -
Effects of resveratrol treatment on bone and cartilage in obese diabetic mice
por: Cooley, Joseph, et al.
Publicado: (2015) -
High-fat, high-sugar diet induces splenomegaly that is ameliorated with exercise and genistein treatment
por: Buchan, Levi, et al.
Publicado: (2018)